Breaking News

Tweet TWEET

Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear

Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in
     Cancer Care with Integration of a Linear Accelerator and MR Imaging

The combination of radiotherapy delivery and simultaneous magnetic resonance
imaging (MRI) is the next-generation innovation for treatment of cancer
patients using radiotherapy

PR Newswire

STOCKHOLM and AMSTERDAM, Oct. 25, 2012

STOCKHOLM and AMSTERDAM, Oct. 25, 2012 /PRNewswire/ --Elekta AB (NSE: EKTAb)
and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that they
will expand a joint program to develop a breakthrough in cancer care with an
imaging-treatment platform that merges radiation therapy and magnetic
resonance imaging (MRI) technology in a single treatment system. The program
for development will include a research consortium of leading radiation
oncology centers and clinicians, which today includes the University Medical
Center Utrecht (the Netherlands).

The establishment of the consortium marks the next step in the collaboration
between Elekta, a pioneer in neurosurgery and radiation therapy systems and
Philips, a leader in medical imaging systems. The consortium's mission will be
to merge precision radiation delivery with MRI in a single MRI-guided
radiation therapy system*. This will enable doctors to achieve exceptional
soft tissue imaging during radiation therapy and to adapt treatment delivery
in real-time for extremely precise cancer treatments.

"Bringing the superior soft tissue imaging of MRI and precise radiotherapy
together in one device could potentially revolutionize cancer care," says
Tomas Puusepp, President and CEO of Elekta AB. "The need to maximize
therapeutic radiation on the target, while minimizing the exposure of healthy
tissue is entirely driven by the best interests of the patient – they deserve
the best chance for a cure and an improved quality of life. Elekta and Philips
are leaders in the global healthcare community with a complete spectrum of
expertise to fulfill this vision."

"Cancer is a major global disease that we hope to control with more targeted
treatments," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare.
"MRI is emerging in oncology applications because of its excellent real-time
3D visualization of soft tissue. Together with our partners, all leaders in
radiation therapy delivery, we are convinced that the  integrated MRI-guided
radiation therapy system has the potential to become a game changer in cancer
care on a global scale."

Working with University Medical Center Utrecht, the medical device companies
have built and tested a prototype system that integrates a linear accelerator
and a 1.5 Tesla MRI system. The success of early tests has enabled the project
to move to the next phase of development and testing by a select group of
consortium partners.

"We are proud and excited about this project," adds Prof. Jan Lagendijk,
Department of Radiotherapy, University Medical Center Utrecht. "Elekta,
Philips and my department have strived for over a decade to make this
possible. Through real-time imaging of both tumors and organs at risk, an
integrated MRI-guided radiation therapy system would enable us to see more
precisely than ever what we treat, and irradiate just the tumor as it moves in
the body during treatment. This could potentially bring significant benefits
to patients and overall healthcare economics."

Radiotherapy is one of the primary modalities used to treat cancer, either as
a stand alone treatment or used with other modalities such as chemotherapy.
The technique involves identifying cancerous tissue and irradiating it with
high energy radiation beams in a way that maximizes sparing of healthy tissue
near the tumor. Radiation therapy delivered by linear accelerators and medical
imaging already play an essential role in treatment planning, delivery and
after care and is a proven cost-effective and safe method for treating
patients with cancer.

*The integrated MRI-guided radiation therapy system is in development and not
available for sale.

For further information, please contact:

Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, E-mail: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management,
Elekta
Tel: +1 770-670-2447, E-mail: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

Steve Klink, Philips Corporate Communications
Tel.: +31 20 5977415, E-mail: steve.klink@philips.com

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care. Stretching the
boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare
providers and patients, Elekta aims to improve, prolong and even save patient
lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHI) is a diversified health and
well-being company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6
billion and employs approximately 122,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care, acute care
and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, home and portable
entertainment and oral healthcare. News from Philips is located at
www.philips.com/newscenter



SOURCE Elekta

Website: http://www.elekta.com
 
Press spacebar to pause and continue. Press esc to stop.